International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-1 doi: 10.5281/zenodo.133714897
Case Report
Synovial Proliferation in Disguise: Case Series of Lipoma Arborescens
Published
Feb. 23, 2025
Abstract

Introduction: Lipoma Arborescens (LA) is a rare, benign synovial condition, primarily affecting the knee, characterized by the growth of adipocytes within the synovial membrane. Case Presentation: Patient 1:A23 year-old male presented with left knee pain and swelling for three months. . Symptoms included stiffness, particularly after rest, and progressive limitation of joint mobility. Patient 2 :A 25 -year-old male presented with right  knee pain and swelling for 8 years. Symptoms included stiffness, particularly after rest, and progressive limitation of joint mobility. Patient 3 :A 22-year-old male presented with progressive swelling and intermittent pain in the leftknee for duration of  2 years . The symptoms were associated with mild stiffness and reduced range of motion. Patient  4 : A 32-year-old male presented with chronic swelling and intermittent pain in the rightknee over the past  5 years . Symptoms included stiffness, particularly after rest, and progressive limitation of joint mobility. There was no history of trauma, systemic symptoms, or prior joint disease in these patients. On examination, a soft, mobile, non-tender mass was palpable, with reduced range of motion Conclusion: Recognizing the MRI features of LA is crucial for accurate diagnosis. Arthroscopic synovectomy offers effective treatment with excellent outcomes.MRI showed characteristic frond-like synovial masses, leading to a diagnosis of LA, confirmed by arthroscopic biopsy.

Recommended Articles
Loading Image...
Volume-6, Issue-1
Citations
1458 Views
258 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved